JP2014500875A - B型肝炎の予防及び治療のためのdnaワクチン組成物 - Google Patents
B型肝炎の予防及び治療のためのdnaワクチン組成物 Download PDFInfo
- Publication number
- JP2014500875A JP2014500875A JP2013539108A JP2013539108A JP2014500875A JP 2014500875 A JP2014500875 A JP 2014500875A JP 2013539108 A JP2013539108 A JP 2013539108A JP 2013539108 A JP2013539108 A JP 2013539108A JP 2014500875 A JP2014500875 A JP 2014500875A
- Authority
- JP
- Japan
- Prior art keywords
- hepatitis
- plasmid
- protein
- recombinant
- vaccine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2010/077979 WO2012065286A1 (zh) | 2010-11-19 | 2010-11-19 | 一种用于预防和治疗乙型肝炎的dna疫苗组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2014500875A true JP2014500875A (ja) | 2014-01-16 |
Family
ID=46083468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013539108A Pending JP2014500875A (ja) | 2010-11-19 | 2010-11-19 | B型肝炎の予防及び治療のためのdnaワクチン組成物 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2014500875A (zh) |
KR (1) | KR20130118890A (zh) |
CN (1) | CN103547286B (zh) |
WO (1) | WO2012065286A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113058033B (zh) * | 2019-12-16 | 2024-07-09 | 远大赛威信生命科学(南京)有限公司 | 一种用于预防和治疗乙型肝炎的药物组合物及其用途 |
WO2023133509A2 (en) * | 2022-01-08 | 2023-07-13 | Carogen Corporation | Multi-antigen therapeutic vaccines to treat or prevent chronic hepatitis b virus infection |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02163089A (ja) * | 1988-12-15 | 1990-06-22 | Dai Ichi Seiyaku Co Ltd | Hbv−dna配列および遺伝子導入動物 |
WO2008020656A1 (en) * | 2006-08-14 | 2008-02-21 | Postech Foundation | A dna vaccine for curing chronic hepatitis b and a method of preparing same |
JP2010516807A (ja) * | 2007-01-31 | 2010-05-20 | トゥビエル カンパニー,リミテッド | Hbvワクチンおよびその製造方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1200106C (zh) * | 1999-06-18 | 2005-05-04 | 中国人民解放军第四五八医院 | 抗乙型肝炎病毒双质粒基因疫苗、其制备方法及应用 |
FR2804028B1 (fr) * | 2000-01-21 | 2004-06-04 | Merial Sas | Vaccins adn ameliores pour animaux de rente |
CN101220373B (zh) * | 2007-01-10 | 2012-01-11 | 深圳市源兴生物医药科技有限公司 | 一种重组病毒载体及其应用 |
-
2010
- 2010-11-19 WO PCT/CN2010/077979 patent/WO2012065286A1/zh active Application Filing
- 2010-11-19 KR KR1020137013827A patent/KR20130118890A/ko not_active Application Discontinuation
- 2010-11-19 JP JP2013539108A patent/JP2014500875A/ja active Pending
- 2010-11-19 CN CN201080070257.4A patent/CN103547286B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02163089A (ja) * | 1988-12-15 | 1990-06-22 | Dai Ichi Seiyaku Co Ltd | Hbv−dna配列および遺伝子導入動物 |
WO2008020656A1 (en) * | 2006-08-14 | 2008-02-21 | Postech Foundation | A dna vaccine for curing chronic hepatitis b and a method of preparing same |
JP2010516807A (ja) * | 2007-01-31 | 2010-05-20 | トゥビエル カンパニー,リミテッド | Hbvワクチンおよびその製造方法 |
Non-Patent Citations (2)
Title |
---|
CSNC201100570033; 大川 和良: '肝炎ワクチンの期待と展望 - B型肝炎DNAワクチンの将来性' 医学のあゆみ 別冊(6月), 19990630, Page.115-117 * |
JPN6014024777; 大川 和良: '肝炎ワクチンの期待と展望 - B型肝炎DNAワクチンの将来性' 医学のあゆみ 別冊(6月), 19990630, Page.115-117 * |
Also Published As
Publication number | Publication date |
---|---|
KR20130118890A (ko) | 2013-10-30 |
WO2012065286A1 (zh) | 2012-05-24 |
CN103547286A (zh) | 2014-01-29 |
CN103547286B (zh) | 2016-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111939250B (zh) | 一种预防covid-19的疫苗及其制备方法 | |
KR100208129B1 (ko) | B형 간염 백신 | |
US7270821B2 (en) | Hepatitis B core antigen fusion proteins | |
US6306625B1 (en) | Method for obtaining expression of mixed polypeptide particles in yeast | |
CN111358953A (zh) | 一种高效诱导机体体液免疫应答的疫苗载体、其制备方法及用途 | |
JP2004510440A (ja) | 高発現可能遺伝子 | |
JPH02501187A (ja) | 新規なワクチンとしての、プレ‐s‐及びs‐ペプチドから選択された、異なるエピトープを含んで成る、組換dna法により調製されたhbv表面抗原粒子 | |
JP2004500868A (ja) | B型肝炎コア抗原の修飾 | |
CA2589698A1 (en) | Improved dna immunization with recombinase/transposase | |
JP2001019643A (ja) | 慢性ウイルス性肝臓病に対する治療薬として用いる組成物 | |
Zhang et al. | Generation of chimeric HBc proteins with epitopes in E. coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo | |
JP6821780B2 (ja) | HBsAgを発現する不活性化全組換えハンセヌラ・ポリモルファ細胞によるB型肝炎治療ワクチン | |
JP5710254B2 (ja) | 外来エピトープを含む組換え偽ウイルスの発現および分泌を可能とするポリヌクレオチド、それらの製造および使用 | |
CN114621357A (zh) | 一种带状疱疹亚单位疫苗及其制备方法 | |
TW202206598A (zh) | 對抗SARS-CoV-2之疫苗及其製品 | |
CN110229219B (zh) | 一种新型的呼吸道合胞病毒疫苗抗原的制备方法及其用途 | |
JP2014500875A (ja) | B型肝炎の予防及び治療のためのdnaワクチン組成物 | |
WO2022089233A1 (zh) | 重组刺突蛋白及其制备方法和用途 | |
CA2446260A1 (en) | Novel expression vectors and uses thereof | |
KR101953374B1 (ko) | 단백질 나노입자 기반의 복합백신 | |
Riedl et al. | Priming biologically active antibody responses against an isolated, conformational viral epitope by DNA vaccination | |
JP2022537324A (ja) | B型肝炎ウイルス(hbv)ワクチンおよび抗pd-1抗体の組合せ | |
JP2022536850A (ja) | B型肝炎ウイルス(hbv)ワクチンおよび抗pd-1または抗pd-l1抗体の組合せ | |
CN115197969B (zh) | 一种治疗乙型肝炎的慢病毒载体、慢病毒颗粒及其制备方法和应用 | |
CN111732667B (zh) | 小反刍兽疫病毒基因工程亚单位疫苗 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140617 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140917 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140925 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141017 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20150331 |
|
RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20150721 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20150721 |